Other mutated genes (including CBL, IDH2, EZH2, ETV6, SETBP1, FLT3-TKD, SRSF2, TP53, PHF6) are less than 5% in NRASmut AML; JAK2 and ZRSR2 mutations are absent in NRASmut AML. This evidence concerns the gene FLT3 and acute myeloid leukemia.